Physician profile
Nancy Collins
NPI 1235250648
$8,921.84
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $7,920 · 2021: $24.81 · 2022: $152 · 2023: $213 · 2024: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,852.33 | 2019-2020 | |
| Abbvie INC. | $195.05 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Daiichi Sankyo INC. | $192.94 | 2019-2024 | Injectafer |
| Optumhealth Care Solutions, LLC | $167.85 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Meditrina | $56.05 | 2023 | |
| Amag Pharmaceuticals, INC. | $50.70 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.00 | 2019-2023 | |
| Becton, Dickinson and Company | $46.37 | 2022 | |
| Duchesnay USA Incorporated | $45.23 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.14 | 2022 | |
| Novo Nordisk INC | $23.04 | 2023 | |
| Exeltis, USA INC. | $17.75 | 2024 | Slynd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.22 | 2019 | |
| Boston Scientific Corporation | $17.13 | 2022 | |
| Organon LLC | $17.05 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $16.57 | 2019 | |
| Avanos Medical | $15.40 | 2024 | On-Q* Pump and Accessories |
| Axonics, INC. | $15.00 | 2023 | Axonics |
| Medicem INC. | $14.93 | 2022 | |
| Pfizer INC. | $14.40 | 2019 | |
| Amgen INC. | $14.17 | 2020 | |
| Therapeuticsmd, INC. | $13.36 | 2019 | |
| Astellas Pharma US INC | $13.05 | 2023 | Veozah |
| Eisai INC. | $12.27 | 2021 | |
| Allergan, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.